Though the primary indication for liver transplant in our patient was treatment of hepatocellular carcinoma, one hypothesis was that a normal liver (with normal PNPO function) would allow hepatic production of PLP, reducing the requirements for PLP doses or allowing management with potentially less toxic B6 vitamers (pyridoxine, pyridoxamine). This evidence concerns the gene PNPO and hepatocellular carcinoma.